START (South Texas Accelerated Research Therapeutics) - Midwest — Grand Rapids, Michigan

START (South Texas Accelerated Research Therapeutics) - Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

START (South Texas Accelerated Research Therapeutics) - Midwest has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors.

Sponsors: MacroGenics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START (South Texas Accelerated Research Therapeutics) - Midwest?

START (South Texas Accelerated Research Therapeutics) - Midwest has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START (South Texas Accelerated Research Therapeutics) - Midwest conducted?

START (South Texas Accelerated Research Therapeutics) - Midwest has 1 clinical trials on record. Their work covers Advanced Solid Tumors.

Is START (South Texas Accelerated Research Therapeutics) - Midwest accredited by Crixeo Health?

START (South Texas Accelerated Research Therapeutics) - Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START (South Texas Accelerated Research Therapeutics) - Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.